Andrew H. Baker

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

Stéphane Heymans, Aernout Luttun, Dieter Nuyens et al. · Nature Medicine · 1999 · 788 citations

Cardiomyopathy, Heart Failure, Cardiovascular Disease +11

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

Jian Qi, Quteba Ebrahem, Nina Z. Moore et al. · Nature Medicine · 2003 · 646 citations

Vegf Receptor-2, Angiogenesis, Novel Function +11

Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer

Simon N. Waddington, John H. McVey, David Bhella et al. · Cell · 2008 · 640 citations · Full text

Hepatology, Genetics, Liver Physiology +6

IL-33 reduces the development of atherosclerosis

Ashley M. Miller, Damo Xu, Darren L. Asquith et al. · The Journal of Experimental Medicine · 2008 · 632 citations · Full text

Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB

Mark Bond, Rosalind P. Fabunmi, Andrew H. Baker et al. · FEBS Letters · 1998 · 510 citations · Full text

Mmp-9 Protein, Immunology, Immune Regulation +22